Ebola at 2,000: the alarm the world keeps ignoring

The Ebola outbreak in the Democratic Republic of Congo has surpassed 2,000 deaths, with confirmed cases exceeding 4,000, according to figures released Tuesday. Al Jazeera reported the death toll passing 2,000, while The Guardian revealed that health officials fear the virus may be mutating, with Africa’s public health watchdog declaring that “the time for incremental action was over.” Authorities announced plans to escalate the response dramatically, including door-to-door patient searches in affected areas. The DRC has suffered more Ebola outbreaks than any other country — fourteen since the virus was first identified near the Ebola River in 1976 — but this outbreak has proved unusually persistent and geographically dispersed, reaching urban centres and posing containment challenges that previous rural-focused outbreaks did not.

The received wisdom

The standard global health framing is that the DRC outbreak persists due to a combination of factors: active armed conflict in eastern Congo that prevents health workers from accessing affected communities, poor infrastructure, community mistrust of formal health services rooted in decades of state failure and, more recently, in COVID-19 vaccine hesitancy campaigns that destabilised trust in public health authority globally. The WHO and Médecins Sans Frontières have consistently called for more funding, more personnel, and greater cooperation from the Congolese government. This framing is largely accurate as a description of proximate causes. The solution it implies — more international resources, more engagement — is the default response that has been applied to every DRC Ebola outbreak with varying degrees of effectiveness.

A different read

The question that the “more resources” framing cannot answer is: why, after fourteen outbreaks spanning fifty years, have the structural conditions that enable Ebola persistence not been addressed?

The DRC is among the most mineral-rich countries on earth. It holds some of the world’s largest reserves of cobalt, coltan, and copper — minerals that are indispensable to electric vehicle batteries, consumer electronics, and the energy transition that Western governments and corporations are racing to complete. The coltan in every smartphone almost certainly passed through supply chains connected to eastern Congo. And yet the Congolese state — hollowed out by decades of Belgian colonial extraction, Cold War proxy warfare, the catastrophic Mobutu kleptocracy, and recurrent regional conflicts — cannot conduct basic public health surveillance in the same territory from which those minerals are extracted.

This is not a case of insufficient aid. The DRC has received tens of billions of dollars in international assistance since independence in 1960. The failure is institutional and structural: a state whose extractive function has been optimised by successive internal and external actors, and whose capacity to deliver services to its own citizens — healthcare, schools, roads, courts — has been systematically subordinated to elite rent extraction. The Guardian noted that health officials are now considering “door to door” searching — an extraordinary measure that implies the surveillance and voluntary reporting systems that are supposed to be Ebola containment’s first line of defence have essentially broken down.

The potential mutation angle raises the stakes considerably. Ebola is an RNA virus with a high mutation rate; previous outbreaks have produced variants with altered transmissibility characteristics. The 2014-2016 West Africa outbreak, which killed more than 11,000 people and briefly sparked global panic when cases reached the United States and Europe, involved a strain with characteristics that public health officials had not previously mapped in detail. If the current DRC outbreak’s pathogen is acquiring new properties — either in terms of transmission efficiency or the immune response it elicits — the calculus for international response shifts from “contained humanitarian crisis” to “potential pandemic precursor.”

Post-COVID, the world’s health governance institutions made many pledges about pandemic preparedness. The WHO’s amended International Health Regulations, agreed in 2024, were meant to strengthen early warning systems and accelerate international response to outbreaks with pandemic potential. Whether those institutional improvements are actually functioning — whether the Congolese government is sharing genomic sequencing data promptly, whether WHO emergency response protocols are triggering at the right thresholds, whether the pharmaceutical industry’s Ebola vaccine stockpiles are adequate — is the set of questions the next few weeks will answer. The optimistic view is that this is a severe but manageable outbreak. The pessimistic view is that we are watching the early stages of a problem that political and bureaucratic incentives are systematically biasing us toward underreacting to.

What to watch

  • Genomic sequencing data from the mutation reports: has the virus acquired changes in the glycoprotein that mediates cell entry, which would be the most concerning scenario for transmissibility?
  • The WHO’s formal risk assessment reclassification: if it upgrades the outbreak to “very high” international risk, it triggers different resource commitments and diplomatic pressure on the DRC government.
  • Armed group behaviour in eastern Congo: the M23 and other factions operating in the outbreak zone have previously obstructed health workers; any escalation of conflict in Ebola-affected areas would be catastrophic for containment.
  • Whether any confirmed cases appear in neighbouring Rwanda, Uganda, or Burundi — which have porous borders with affected DRC provinces and significantly better health infrastructure, meaning they would likely contain rather than amplify spread.

— J